Opiate Substitution Treatment
8
1
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
25%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
A Chatbot To Support Substance Use Recovery
Use of a GLP-1R Agonist to Treat Opioid Use Disorder
Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder
Extended-release Pharmacotherapy for Opioid Use Disorder
Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence